Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

Oncotarget

Volumn 6, Issue 8, 2015, Pages 5634-5649

  Krøigård, Anne Bruun ^a,b   Larsen, Martin Jakob ^a,b   Lænkholm, Anne Vibeke ^c   Knoop, Ann S ^d   Jensen, Jeanette D ^a   Bak, Martin ^a   Mollenhauer, Jan ^b,e   Kruse, Torben A ^a,b,e   Thomassen, Mads ^a,b,e  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c SLAGELSE HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

^e Lundbeckfonden Center of Excellence in Nanomedicine NanoCAN   (Denmark)

Author keywords

Breast cancer; Copy number aberrations; Linear progression model; Metastasis models

Indexed keywords

ANASTROZOLE; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GEMCITABINE; TAMOXIFEN;

ADULT; ARTICLE; CANCER GENETICS; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CELL CLONE; CELL EXPANSION; COPY NUMBER VARIATION; EXOME; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MASTECTOMY; METASTASIS; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; MULTIPLE CYCLE TREATMENT; MUTATION RATE; POINT MUTATION; SEQUENCE ANALYSIS; SOMATIC MUTATION; TREATMENT DURATION; TUMOR INVASION; BREAST TUMOR; DISEASE COURSE; EPIDEMIOLOGY; FEMALE; GENETICS; GENOME; PATHOLOGY; STATISTICAL MODEL;

BREAST NEOPLASMS; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; EPIDEMIOLOGIC METHODS; FEMALE; GENOME; HUMANS; LINEAR MODELS; NEOPLASM METASTASIS; NEOPLASM STAGING;

EID: 84925679415     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3111     Document Type: Article

References (35)

1. Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011; 144:646-674.
2. Yates LR, Campbell PJ. Evolution of the cancer genome. Nat Rev Genet. 2012; 13:795-806.
3. Nguyen DX, Massagué J. Genetic determinants of cancer metastasis. Nat Rev Genet. 2007; 8:341-352.
4. Nowell PC. The Clonal Evolution of Tumor Cell Populations. Science. 1976; 194:23-28. [New Series].
5. Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity:a looking glass for cancer? Nat Rev Cancer. 2012; 12:323-334.
6. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009; 9:302-312.
7. Fudenberg G, Getz G, Meyerson M, Mirny LA. High order chromatin architecture shapes the landscape of chromosomal alterations in cancer. Nat Biotechnol. 2011; 29:1109-1113.
8. De S, Michor F. DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes. Nat Biotechnol. 2011; 29:1103-1108.
9. De S, Michor F. DNA secondary structures and epigenetic determinants of cancer genome evolution. Nat Struct Mol Biol. 2011; 18:950-955.
10. Li Y, Zhang L, Ball RL, Liang X, Li J, Lin Z, Liang H. Comparative analysis of somatic copy-number alterations across different human cancer types reveals two distinct classes of breakpoint hotspots. Hum Mol Genet. 2012; 21:4957-4965.
11. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, McLaren S, Lin M-L, McBride DJ, Varela I, Nik-Zainal S, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Quail MA, Burton J, Swerdlow H, Carter NP, Morsberger LA, Iacobuzio-Donahue C, Follows GA, Green AR, Flanagan AM, Stratton MR, Futreal PA, Campbell PJ. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development. Cell. 2011; 144:27-40.
12. Marotta M, Chen X, Watanabe T, Faber PW, Diede SJ, Tapscott S, Tubbs R, Kondratova A, Stephens R, Tanaka H. Homology-mediated end-capping as a primary step of sister chromatid fusion in the breakage-fusion-bridge cycles. Nucleic Acids Res. 2013; 41:9732-9740.
13. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A CENSUS OF HUMAN CANCER GENES. Nat Rev Cancer. 2004; 4:177-183.
14. Gyorffy B, Lánczky A, Szállási Z. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr Relat Cancer. 2012; 19:197-208.
15. Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, Sougnez C, Stewart C, Sivachenko A, Wang L, Wan Y, Zhang W, Shukla SA, Vartanov A, Fernandes SM, Saksena G, Cibulskis K, Tesar B, Gabriel S, Hacohen N, Meyerson M, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia. Cell. 2013; 152:714-726.
16. Park SY, Gönen M, Kim HJ, Michor F, Polyak K. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest. 2010; 120:636-644.
17. Polyak K. Heterogeneity in breast cancer. J Clin Invest. 2011; 121:3786-3788.
18. Hoefnagel LDC, van der Groep P, van de Vijver MJ, Boers JE, Wesseling P, Wesseling J, Dutch Distant Breast Cancer Metastases Consortium, van der Wall E, van Diest PJ. Discordance in ERa, PR and HER2 receptor status across different distant breast cancer metastases within the same patient. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2013; 24:3017-3023.
19. Friedrich K, Weber T, Scheithauer J, Meyer W, Haroske G, Kunze KD, Baretton G. Chromosomal genotype in breast cancer progression: Comparison of primary and secondary manifestations. Cell Oncol. 2008; 30:39-50.
20. Nishizaki T, DeVries S, Chew K, Goodson WH, Ljung B-M, Thor A, Waldman FM. Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer. 1997; 19:267-272.
21. Li J, Gromov P, Gromova I, Moreira JM, Timmermans-Wielenga V, Rank F, Wang K, Li S, Li H, Wiuf C, Yang H, Zhang X, Bolund L, Celis JE. Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis. Proteomics. 2008; 8:5038-5052.
22. Poplawski AB, Jankowski M, Erickson SW, Diaz de Stahl T, Partridge EC, Crasto C, Guo J, Gibson J, Menzel U, Bruder CE, Kaczmarczyk A, Benetkiewicz M, Andersson R, Sandgren J, Zegarska B, Bala D, Srutek E, Allison DB, Piotrowski A, Zegarski W, Dumanski JP. Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression. Eur J Hum Genet. 2010; 18:560-568.
23. Moelans CB, van der Groep P, Hoefnagel LDC, van de Vijver MJ, Wesseling P, Wesseling J, van der Wall E, van Diest PJ. Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes. Cancer Lett. 2014; 344:138-146.
24. Meric-Bernstam F, Frampton GM, Ferrer-Lozano J, Yelensky R, Pérez-Fidalgo JA, Wang Y, Palmer GA, Ross JS, Miller VA, Su X, Eroles P, Barrera JA, Burgues O, Lluch AM, Zheng X, Sahin A, Stephens PJ, Mills GB, Cronin MT, Gonzalez-Angulo AM. Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer. Mol Cancer Ther. 2014; 13:1382-1389.
25. Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, Abbott RM, Hoog J, Dooling DJ, Koboldt DC, Schmidt H, Kalicki J, Zhang Q, Chen L, Lin L, Wendl MC, McMichael JF, Magrini VJ, Cook L, McGrath SD, Vickery TL, Appelbaum E, DeSchryver K, Davies S, Guintoli T, Lin L, Crowder R, Tao Y, Snider JE, Smith SM, Dukes AF, Sanderson GE, Pohl CS, Delehaunty KD, Fronick CC, Pape KA, Reed JS, Robinson JS, Hodges JS, Schierding W, Dees ND, Shen D, Locke DP, Wiechert ME, Eldred JM, Peck JB, Oberkfell BJ, Lolofie JT, Du F, Hawkins AE, O'Laughlin MD, Bernard KE, Cunningham M, Elliott G, Mason MD, Thompson Jr DM, Ivanovich JL, Goodfellow PJ, Perou CM, Weinstock GM, Aft R, Watson M, Ley TJ, Wilson RK, Mardis ER. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature. 2010; 464:999-1005.
26. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, Steidl C, Holt RA, Jones S, Sun M, Leung G, Moore R, Severson T, Taylor GA, Teschendorff AE, Tse K, Turashvili G, Varhol R, Warren RL, Watson P, Zhao Y, Caldas C, Huntsman D, Hirst M, Marra MA, Aparicio S. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 2009; 461:809-813.
27. Marino N, Collins JW, Shen C, Caplen NJ, Merchant AS, Gökmen-Polar Y, Goswami CP, Hoshino T, Qian Y, Sledge GW, Steeg PS. Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines. Clin Exp Metastasis. 2014; 31:771-786.
28. Baylin SB, Jones PA. A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer. 2011; 11:726-734.
29. Reyngold M, Turcan S, Giri D, Kannan K, Walsh LA, Viale A, Drobnjak M, Vahdat LT, Lee W, Chan TA. Remodeling of the methylation landscape in breast cancer metastasis. PloS One. 2014; 9:e103896.
30. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011; 43:491-498.
31. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012; 22:568-576.
32. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38:e164-e164.
33. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009; 4:1073-1081.
34. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7:248-249.
35. Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010; 7:575-576.